inrebicpro.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Sitemap:
Meta Tags
Title INREBIC® (fedratinib) | For Healthcare
Description INDICATION INREBIC® (fedratinib) is a treatment for adult patients with INT-2 or high-risk myelofibrosis. See full Prescribing Information, including Boxed Warning on encephalopathy, including
Keywords N/A
Server Information
WebSite inrebicpro faviconinrebicpro.com
Host IP 45.60.170.161
Location United States
Related Websites
Site Rank
More to Explore
inrebicpro.com Valuation
US$2,341,490
Last updated: 2023-05-12 09:23:40

inrebicpro.com has Semrush global rank of 4,520,329. inrebicpro.com has an estimated worth of US$ 2,341,490, based on its estimated Ads revenue. inrebicpro.com receives approximately 270,172 unique visitors each day. Its web server is located in United States, with IP address 45.60.170.161. According to SiteAdvisor, inrebicpro.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,341,490
Daily Ads Revenue US$2,162
Monthly Ads Revenue US$64,842
Yearly Ads Revenue US$778,095
Daily Unique Visitors 18,012
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
inrebicpro.com. A 299 IP: 45.60.170.161
inrebicpro.com. A 299 IP: 45.60.150.161
inrebicpro.com. NS 86400 NS Record: ns-1822.awsdns-35.co.uk.
inrebicpro.com. NS 86400 NS Record: ns-1013.awsdns-62.net.
inrebicpro.com. NS 86400 NS Record: ns-123.awsdns-15.com.
inrebicpro.com. NS 86400 NS Record: ns-1239.awsdns-26.org.
inrebicpro.com. MX 1800 MX Record: 10 inbound-smtp.us-east-1.amazonaws.com.
inrebicpro.com. TXT 300 TXT Record: google-site-verification=I3hkfD1omMpHAG7LICatSMTul2aQ3EplisqhB1T7hGE
HtmlToTextCheckTime:2023-05-12 09:23:40
Indication US full prescribing info including boxed warning Medication guide BMS connect --> BMS Connect Patient site Indication Medication guide About INREBIC ® Efficacy & Safety Starting INREBIC ® Managing Risks Resources & Access BMS Connect --> BMS Connect Patient Site US Full Prescribing Information including BOXED WARNING INDICATION INREBIC ® (fedratinib) is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). Proceed to Site X GO ALL IN --> IN REBIC ® FROM THE START --> For adult patients with intermediate-2 or high-risk myelofibrosis (MF) who have platelet counts ≥50 × 10 9 /L 1 DISCOVER MORE ABOUT INREBIC ® GO ALL IN --> IN REBIC ® FROM THE START --> For adult patients with intermediate-2 or high-risk myelofibrosis (MF) who have platelet counts ≥50 × 10 9 /L 1 DISCOVER MORE ABOUT INREBIC ® For adult patients with intermediate-2 or
HTTP Headers
HTTP/1.1 301 Moved Permanently
Location: https://inrebicpro.com/
Content-Length: 0
Connection: close

HTTP/2 301 
date: Sat, 11 Dec 2021 08:26:27 GMT
content-type: text/html; charset=iso-8859-1
set-cookie: AWSALBTG=Xox7V6ZFiVBRd1fIshs4vl7bxWjQbIwgRifiZWuQaeN8Lfk0wJ1D2NuxsZ2rWNCLKl2HwnvMBH3itz4GyE+hkSaE2FCdOpJrA3jysu9CRH/oLqfXTve711mgh/abV23a6kgKbnkZkGEgMR+euwJQh3DVhVA6BnbAqPoQLWZXcE6gauyCyJY=; Expires=Sat, 18 Dec 2021 08:26:27 GMT; Path=/
set-cookie: AWSALBTGCORS=Xox7V6ZFiVBRd1fIshs4vl7bxWjQbIwgRifiZWuQaeN8Lfk0wJ1D2NuxsZ2rWNCLKl2HwnvMBH3itz4GyE+hkSaE2FCdOpJrA3jysu9CRH/oLqfXTve711mgh/abV23a6kgKbnkZkGEgMR+euwJQh3DVhVA6BnbAqPoQLWZXcE6gauyCyJY=; Expires=Sat, 18 Dec 2021 08:26:27 GMT; Path=/; SameSite=None; Secure
server: Apache
location: https://www.inrebicpro.com/
set-cookie: AWSALBAPP-0=_remove_; Expires=Sat, 18 Dec 2021 08:26:27 GMT; Path=/
set-cookie: AWSALBAPP-1=_remove_; Expires=Sat, 18 Dec 2021 08:26:27 GMT; Path=/
set-cookie: AWSALBAPP-2=_remove_; Expires=Sat, 18 Dec 2021 08:26:27 GMT; Path=/
set-cookie: AWSALBAPP-3=_remove_; Expires=Sat, 18 Dec 2021 08:26:27 GMT; Path=/
set-cookie: visid_incap_2613599=9TWn4ebJS6SPrSDgKSp80LNgtGEAAAAAQUIPAAAAAABh4TNXK0oGbTnuPEUM6Rzc; expires=Sat, 10 Dec 2022 11:40:38 GMT; HttpOnly; path=/; Domain=.inrebicpro.com
set-cookie: incap_ses_1291_2613599=5y05W/c0uQaltiiICI7qEbNgtGEAAAAA9fCljY1qs/Dhk56TTENkCA==; path=/; Domain=.inrebicpro.com
x-cdn: Imperva
x-iinfo: 14-906338995-906196716 pNNN RT(1639211187565 0) q(0 0 0 0) r(1 1) U6

HTTP/2 200 
date: Sat, 11 Dec 2021 08:26:28 GMT
content-type: text/html; charset=UTF-8
set-cookie: AWSALBTG=fQt6wBCDFXepK/YfAHqeYOMJP4enADcC5E00gnhoetPt2Gg0Lt9LvpIwDOtW4wH8QHg6PSYvEwjus8t/OlSX8DZxkm8ka0OojNHqIpSGkthIazRiSuSmPBpHTUgf2p11lPTO5T/xbu/HgIkIXHXJbDhJWCUg3UILMtdyMv42y0vRRmNK6NY=; Expires=Sat, 18 Dec 2021 08:26:27 GMT; Path=/
set-cookie: AWSALBTGCORS=fQt6wBCDFXepK/YfAHqeYOMJP4enADcC5E00gnhoetPt2Gg0Lt9LvpIwDOtW4wH8QHg6PSYvEwjus8t/OlSX8DZxkm8ka0OojNHqIpSGkthIazRiSuSmPBpHTUgf2p11lPTO5T/xbu/HgIkIXHXJbDhJWCUg3UILMtdyMv42y0vRRmNK6NY=; Expires=Sat, 18 Dec 2021 08:26:27 GMT; Path=/; SameSite=None; Secure
server: Apache
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-xss-protection: 1; mode=block
set-cookie: AWSALBAPP-0=_remove_; Expires=Sat, 18 Dec 2021 08:26:28 GMT; Path=/
set-cookie: AWSALBAPP-1=_remove_; Expires=Sat, 18 Dec 2021 08:26:28 GMT; Path=/
set-cookie: AWSALBAPP-2=_remove_; Expires=Sat, 18 Dec 2021 08:26:28 GMT; Path=/
set-cookie: AWSALBAPP-3=_remove_; Expires=Sat, 18 Dec 2021 08:26:28 GMT; Path=/
set-cookie: visid_incap_2613599=ejTzL3JoTiiY8wou2imXx7JgtGEAAAAAQUIPAAAAAAC6AkUXCrBJRVK//Wks/oST; expires=Sat, 10 Dec 2022 12:55:31 GMT; HttpOnly; path=/; Domain=.inrebicpro.com
set-cookie: incap_ses_1464_2613599=RW58EevovQpL/7ftVyxRFLNgtGEAAAAAmUIiURTatkatRns15pquaw==; path=/; Domain=.inrebicpro.com
x-cdn: Imperva
x-iinfo: 14-25462637-25349801 pNNN RT(1639211186822 0) q(0 0 0 0) r(4 4) U6
inrebicpro.com Whois Information
Domain Name: INREBICPRO.COM
Registry Domain ID: 2369544926_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-03-11T06:19:18Z
Creation Date: 2019-03-15T17:42:10Z
Registry Expiry Date: 2022-03-15T17:42:10Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-1013.AWSDNS-62.NET
Name Server: NS-123.AWSDNS-15.COM
Name Server: NS-1239.AWSDNS-26.ORG
Name Server: NS-1822.AWSDNS-35.CO.UK
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-11T08:11:08Z <<<

Copyright © 2022 WebZZ.US 0.0230